Completed
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
I3Y-MC-JPBX - ClinicalTrials.gov - NCT02450539
The main purpose of this study is to evaluate the effectiveness of the study drug known as abemaciclib versus docetaxel in participants with stage IV squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy.
How long will I be in the trial?
You can participate in this study for as long as your study doctor determines that you are benefiting from the study treatment
Completed
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
I3Y-MC-JPBX - ClinicalTrials.gov - NCT02450539
The main purpose of this study is to evaluate the effectiveness of the study drug known as abemaciclib versus docetaxel in participants with stage IV squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy.
How long will I be in the trial?
You can participate in this study for as long as your study doctor determines that you are benefiting from the study treatment
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participant must have a confirmed diagnosis of stage IV Squamous NSCLC
Participant must have progressed during or after platinum-based chemotherapy
Participant must be fully active or if restricted in physically strenuous activity should be able to walk and carry out light work, e.g., light house work, office work
Participant must agree to use a reliable medically approved method of birth control
Participants must NOT
Participant must not have received prior treatment with docetaxel
Participant must not have received prior treatment with any cyclin dependent kinase (CDK) 4 and 6 inhibitor or participated in a clinical trial with a CDK 4 and 6 inhibitor where the treatment administered is not known
Participant must not be currently receiving treatment in a clinical trial involving an investigational product or non-approved use of a drug or device
Trial Summary
Conditions the trial is for
Non-small Cell Lung Cancer
What the trial is testing?
Abemaciclib (LY2835219), Docetaxel
Could I receive a Placebo?
no
Enrollment Goal
150
Trial Dates
August 2015 - July 2020
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participant must have a confirmed diagnosis of stage IV Squamous NSCLC
Participant must have progressed during or after platinum-based chemotherapy
Participant must be fully active or if restricted in physically strenuous activity should be able to walk and carry out light work, e.g., light house work, office work
Participant must agree to use a reliable medically approved method of birth control
Participants must NOT
Participant must not have received prior treatment with docetaxel
Participant must not have received prior treatment with any cyclin dependent kinase (CDK) 4 and 6 inhibitor or participated in a clinical trial with a CDK 4 and 6 inhibitor where the treatment administered is not known
Participant must not be currently receiving treatment in a clinical trial involving an investigational product or non-approved use of a drug or device
Trial Summary
Conditions the trial is for
Non-small Cell Lung Cancer
What the trial is testing?
Abemaciclib (LY2835219), Docetaxel
Could I receive a Placebo?
no
Enrollment Goal
150
Trial Dates
August 2015 - July 2020
Trial Phase
2
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Non-small Cell Lung Cancer Resources
